GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jiangsu Nanfang Medical Co 603880.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

7.72

-0.26%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Jiangsu Nanfang Medical Co

Its shares trade on Shanghai under the ticker 603880.SS. It has been listed since 7 August 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥600.5m and a net loss of CN¥101.7m. At that date it held total assets of CN¥927.9m and shareholders' equity of CN¥177.2m.

Jiangsu Nanfang Medical Co., Ltd. engages in the research, development, manufacture, and sale of transdermal, medical bondage, and sports protection, first-aid kits and care products. The company is headquartered in Changzhou, Jiangsu. The company went IPO on 2017-08-07. The firm is mainly engaged in research and development, manufactures and sales of transdermal products, medical tape and bandages, sports protection products, first-aid kits, nursing products and others. The Company’s main products include Band-Aid, patches, medical tapes, plaster dressings, sports protection products, first-aid kits, care products and other products. The Company’s brands include MIAO-SHOU, Oushun and others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
7 Aug 2017
Employees
1,002

Leadership

Pay as last reported

  • Mr. Ping LiChairman of the Board, General Manager
  • Ms. Qinhua XiangChief Financial Officer, Director, Finance Manager
  • Mr. Guoping ZhuangDeputy General Manager, Director, since 2012
  • Ms. Yafen WuDeputy General Manager
  • Ms. Linye XuSecretary of the Board
  • Mr. Yongping LiDirector
  • Mr. Yongzhong LiDirector
  • Ms. Ping WuDirector
  • Mr. Ao GuoIndependent Director
  • Mr. Yubin LiIndependent Director
  • Mr. Minxian SongIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Jiangsu Nanfang Medical employs 1,002 skilled workers in Changzhou, China.
  • The company develops transdermal products and medical tapes for global markets.
  • MIAO-SHOU and Oushun are recognized brands in healthcare products.

Weaknesses

  • The company's IPO date was 7 August 2017, which may limit recent growth.
  • Jiangsu Nanfang Medical's headquarters in Changzhou, China, may face logistical challenges.
  • The firm's focus on transdermal products could be vulnerable to market shifts.

Opportunities

  • Expanding into the global health care market for transdermal products.
  • Growing demand for sports protection products in China's sports industry.
  • Increasing sales of first-aid kits in the Chinese healthcare sector.

Threats

  • Competition from established brands in the medical tape industry.
  • Rising costs of raw materials for medical products in China.
  • Regulatory changes affecting healthcare product manufacturing in China.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.